David Martin, M.D., Ph.D., FASA, has disclosed Royalties/Equity Position with Nevro and Michael Loushin, M.D., has disclosed Stock options/Equity Postion with Preceptis Medical, Inc.
All other faculty, planners and staff have disclosed no relevant financial relationships with commercial interests.